# Research on the Treatment of Severe Community-acquired Pneumonia in Children

> **NCT05768204** · PHASE4 · UNKNOWN · sponsor: **Baoping XU** · enrollment: 160 (estimated)

## Conditions studied

- Severe Pneumonia

## Interventions

- **DRUG:** Prednisolone Acetate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05768204
- **Lead sponsor:** Baoping XU
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-10
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05768204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05768204, "Research on the Treatment of Severe Community-acquired Pneumonia in Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05768204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*